Rapha Myr
Anoikis
/ drug effects
Antineoplastic Combined Chemotherapy Protocols
/ pharmacology
Astrocytoma
/ drug therapy
Cell Line, Tumor
DNA Methylation
/ drug effects
DNA, Neoplasm
/ metabolism
Glycoside Hydrolases
/ pharmacology
Humans
Isothiocyanates
/ pharmacology
Neoplasm Proteins
/ metabolism
Sirtuins
/ metabolism
Sulfoxides
anoikis
apoptosis
astrocytoma 1321N1 cells
brain cancer
cell migration
cytoskeleton morphology
global DNA methylation
mutated p53 R213Q
myrosinase
oxidative stress
sirtuins
sulforaphane
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
27 Jul 2020
27 Jul 2020
Historique:
received:
12
07
2020
accepted:
23
07
2020
entrez:
31
7
2020
pubmed:
31
7
2020
medline:
18
2
2021
Statut:
epublish
Résumé
Brain and other nervous system cancers are the 10th leading cause of death worldwide. Genome instability, cell cycle deregulation, epigenetic mechanisms, cytoarchitecture disassembly, redox homeostasis as well as apoptosis are involved in carcinogenesis. A diet rich in fruits and vegetables is inversely related with the risk of developing cancer. Several studies report that cruciferous vegetables exhibited antiproliferative effects due to the multi-pharmacological functions of their secondary metabolites such as isothiocyanate sulforaphane deriving from the enzymatic hydrolysis of glucosinolates. We treated human astrocytoma 1321N1 cells for 24 h with different concentrations (0.5, 1.25 and 2.5%
Identifiants
pubmed: 32727075
pii: ijms21155328
doi: 10.3390/ijms21155328
pmc: PMC7432334
pii:
doi:
Substances chimiques
DNA, Neoplasm
0
Isothiocyanates
0
Neoplasm Proteins
0
Sulfoxides
0
Glycoside Hydrolases
EC 3.2.1.-
thioglucosidase
EC 3.2.1.147
Sirtuins
EC 3.5.1.-
sulforaphane
GA49J4310U
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Biochim Biophys Acta. 2013 Dec;1833(12):3481-3498
pubmed: 23830918
Int J Mol Sci. 2015 Dec 12;16(12):29732-43
pubmed: 26703571
Cornea. 2018 Aug;37(8):1058-1063
pubmed: 29634672
Oncotarget. 2018 Nov 20;9(91):36289-36316
pubmed: 30555630
Pharmacol Res. 2011 Nov;64(5):456-63
pubmed: 21816223
Toxicol Appl Pharmacol. 2019 Jan 1;362:116-124
pubmed: 30365975
Front Pharmacol. 2013 May 07;4:57
pubmed: 23675348
J Cell Biol. 2000 Mar 6;148(5):1075-90
pubmed: 10704455
Oncol Lett. 2017 Jan;13(1):441-448
pubmed: 28123580
J Cell Sci. 2011 Oct 1;124(Pt 19):3189-97
pubmed: 21940791
Mol Nutr Food Res. 2016 May;60(5):1068-78
pubmed: 26918318
Cytometry A. 2014 Jun;85(6):512-21
pubmed: 24515854
J Nutrigenet Nutrigenomics. 2015;8(2):91-101
pubmed: 26372775
Front Cell Dev Biol. 2020 Mar 06;8:100
pubmed: 32211401
Molecules. 2020 Feb 07;25(3):
pubmed: 32046220
Cancer Res. 2006 Jun 15;66(12):6002-7
pubmed: 16778170
Oncogene. 2000 Jun 22;19(27):3095-100
pubmed: 10871862
Nutrients. 2017 Apr 10;9(4):
pubmed: 28394276
Cancer Treat Res. 2014;159:207-23
pubmed: 24114482
Metabolism. 2015 Mar;64(3 Suppl 1):S16-21
pubmed: 25468140
Int J Mol Sci. 2019 Jun 03;20(11):
pubmed: 31163602
Biochem Biophys Res Commun. 2008 Dec 12;377(2):341-345
pubmed: 18854174
Chem Res Toxicol. 2019 May 20;32(5):935-942
pubmed: 31016965
Carcinogenesis. 2008 Dec;29(12):2360-8
pubmed: 18952594
Oncotarget. 2016 Apr 12;7(15):19201-13
pubmed: 27034011
Top Curr Chem. 2013;329:163-77
pubmed: 22752583
Nutrients. 2019 Sep 02;11(9):
pubmed: 31480794
Oncol Rep. 2016 Oct;36(4):2298-304
pubmed: 27573437
NPJ Precis Oncol. 2019 Jan 28;3:3
pubmed: 30701196
Nutrients. 2019 Jun 29;11(7):
pubmed: 31261930
Nutrients. 2018 Nov 14;10(11):
pubmed: 30441761
Biomolecules. 2020 Feb 26;10(3):
pubmed: 32111081
Cell Signal. 2012 Feb;24(2):393-401
pubmed: 22024283
Front Pharmacol. 2019 Jan 30;10:38
pubmed: 30761005
Clin Epigenetics. 2016 May 25;8:61
pubmed: 27226812
Front Genet. 2019 Mar 01;10:79
pubmed: 30881375
Mol Nutr Food Res. 2011 Jul;55(7):999-1009
pubmed: 21374800
Mol Med Rep. 2019 Apr;19(4):2599-2610
pubmed: 30816460
Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):E384-93
pubmed: 24324133
Food Funct. 2017 Dec 13;8(12):4713-4722
pubmed: 29165474
Oncotarget. 2016 Sep 20;7(38):62194-62207
pubmed: 27613837
Biochimie. 2014 Apr;99:215-8
pubmed: 24384472
Cancer Lett. 2017 May 28;394:52-64
pubmed: 28254410
Semin Cancer Biol. 2015 Dec;35 Suppl:S276-S304
pubmed: 26590477
Adv Exp Med Biol. 2019;1152:293-310
pubmed: 31456191
Oxid Med Cell Longev. 2016;2016:3031459
pubmed: 27379175
PLoS One. 2008;3(12):e4020
pubmed: 19107194
Sci Rep. 2017 Oct 4;7(1):12651
pubmed: 28978924
Cancer Discov. 2014 Apr;4(4):405-14
pubmed: 24658082
J Neurosci Res. 2014 Jan;92(1):95-103
pubmed: 24123177
Science. 2017 Jul 21;357(6348):
pubmed: 28729483
Int J Mol Sci. 2018 Jun 13;19(6):
pubmed: 29899271
Nature. 2006 Jan 5;439(7072):95-9
pubmed: 16397500
Cancer Res. 2016 Sep 15;76(18):5189-91
pubmed: 27635040
Cold Spring Harb Perspect Biol. 2010 Jan;2(1):a001008
pubmed: 20182602
J Cell Commun Signal. 2018 Mar;12(1):91-101
pubmed: 28735362
Biomarkers. 2015 Feb;20(1):64-70
pubmed: 25518886
Int J Oncol. 2016 Jun;48(6):2521-33
pubmed: 27035641
Theranostics. 2017 Aug 15;7(14):3461-3477
pubmed: 28912888
Cancer Prev Res (Phila). 2012 Apr;5(4):603-11
pubmed: 22318753
Int J Mol Sci. 2019 Oct 09;20(20):
pubmed: 31600949
Clin Cancer Res. 2010 Sep 15;16(18):4532-42
pubmed: 20823146
Brain Tumor Pathol. 2000;17(2):65-70
pubmed: 11210173
Acta Pharmacol Sin. 2009 May;30(5):501-12
pubmed: 19417730
Oncotarget. 2017 Aug 21;8(49):86947-86968
pubmed: 29156849
Vet Med Sci. 2018 Nov;4(4):357-363
pubmed: 30117668
Clin Genet. 2012 Apr;81(4):303-11
pubmed: 22082348
Mutagenesis. 2015 May;30(3):421-30
pubmed: 25681790